(Q43728171)

26 November 2017

title

Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide (English)

1 reference

26 November 2017

Morandi P

1

1 reference

26 November 2017

Ruffini PA

2

1 reference

26 November 2017

Benvenuto GM

3

1 reference

26 November 2017

La Vecchia L

4

1 reference

26 November 2017

Mezzena G

5

1 reference

26 November 2017

Raimondi R

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Bone Marrow Transplantation

26 November 2017

published in

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

277-282

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703132

26 November 2017

exact match

0 references

cites work

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Cardiac troponin I and troponin T: recent players in the field of myocardial markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Much ado about not...enough data: high-dose chemotherapy with autologous stem cell rescue for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Rescue PTCA for a Totally Occluded Left Main Coronary Artery in Acute Myocardial Infarction with Cardiogenic Shock: Technical Success and Long-Term Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Troponins in prediction of cardiotoxic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Markers of myocardial injury in blood following PTCA: a comparison of CKMB, cardiospecific troponin T and troponin I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Cardiac troponin T in patients with clinically suspected myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Kinetics of hematopoietic progenitor cell release induced by G-CSF-alone in children with solid tumors and leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Serum cardiac troponin T levels during treatment of early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Serum troponin T levels in adults undergoing anthracycline therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Troponins for predicting cardiotoxicity from cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Pharmacokinetics of "activated" cyclophosphamide and therapeutic efficacies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703132

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703132

1 reference

Dimensions Publication ID

26 November 2017

1025300738

0 references

1 reference